Corrigendum to Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity [EMBO Mol Med, 6, (2014), 1493-1507], DOI 10.15252/emmm.201404190;Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity

EMBO Molecular Medicine

Volumn 6, Issue 11, 2014, Pages 1493-1507

  Guan, Jian ^a   Mishra, Shikha ^a   Qiu, Yiling ^a   Shi, Jianru ^a,c   Trudeau, Kyle ^b   Las, Guy ^b   Liesa, Marc ^b   Shirihai, Orian S ^b   Connors, Lawreen H ^b   Seldin, David C ^b   Falk, Rodney H ^a   Macrae, Calum A ^a   Liao, Ronglih ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Amyloidosis; Autophagy; Cardiac toxicity; Lysosome; Mitochondria

Indexed keywords

AMYLOID; IMMUNOGLOBULIN LIGHT CHAIN; RAPAMYCIN;

AMYLOIDOSIS; ARTICLE; AUTOPHAGY; CARDIOMYOPATHY; CARDIOTOXICITY; CELL DEATH; CONTROLLED STUDY; IN VIVO STUDY; LYSOSOME; NONHUMAN; PATHOGENESIS; SURVIVAL; ZEBRA FISH; ANIMAL; CARDIAC MUSCLE; DISEASE MODEL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL ANALYSIS; WISTAR RAT;

AMYLOIDOSIS; ANIMALS; AUTOPHAGY; CARDIOTOXICITY; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN LIGHT CHAINS; LYSOSOMES; MYOCARDIUM; RATS, WISTAR; SURVIVAL ANALYSIS; ZEBRAFISH;

EID: 84910678527     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.15252/emmm.201505318     Document Type: Erratum

References (33)

1. Bhuiyan MS, Pattison JS, Osinska H, James J, Gulick J, McLendon PM, Hill JA, Sadoshima J, Robbins J (2013) Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest 123: 5284-5297
2. Bove J, Martinez-Vicente M, Vila M (2011) Fighting neurodegeneration with rapamycin: mechanistic insights. Nat Rev Neurosci 12: 437-452
3. Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M, Apstein CS, Liao R (2004) Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 94: 1008-1010
4. Cai Z, Yan LJ (2013) Rapamycin, autophagy, and Alzheimer's disease. J Biochem Pharmacol Res 1: 84-90
5. Codogno P (2014) Shining light on autophagy. Nat Rev Mol Cell Biol 15: 153
6. Connors LH, Jiang Y, Budnik M, Theberge R, Prokaeva T, Bodi KL, Seldin DC, Costello CE, Skinner M (2007) Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains. Biochemistry 46: 14259-14271
7. Cortes CJ, Qin K, Cook J, Solanki A, Mastrianni JA (2012) Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Straussler-Scheinker disease. J Neurosci 32: 12396-12405
8. Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Bjorklund A (2013) TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc Natl Acad Sci U S A 110: E1817-E1826
9. Dehay B, Bove J, Rodriguez-Muela N, Perier C, Recasens A, Boya P, Vila M (2010) Pathogenic lysosomal depletion in Parkinson's disease. J Neurosci 30: 12535-12544
10. Eskelinen EL, Saftig P (2009) Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 1793: 664-673
11. Falk RH (2005) Diagnosis and management of the cardiac amyloidoses. Circulation 112: 2047-2060
12. Falk RH (2011) Cardiac amyloidosis: a treatable disease, often overlooked. Circulation 124: 1079-1085
13. Guan J, Mishra S, Shi J, Plovie E, Qiu Y, Cao X, Gianni D, Jiang B, Del Monte F, Connors LH et al (2013) Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol 108: 378
14. Hamacher-Brady A, Brady NR, Gottlieb RA (2006) Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 281: 29776-29787
15. Harris H, Rubinsztein DC (2012) Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 8: 108-117
16. Jain M, Brenner DA, Cui L, Lim CC, Wang B, Pimentel DR, Koh S, Sawyer DB, Leopold JA, Handy DE et al (2003) Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes. Circ Res 93: e9-e16
17. Kubli DA, Gustafsson AB (2012) Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 111: 1208-1221
18. Liao R, Jain M, Teller P, Connors LH, Ngoy S, Skinner M, Falk RH, Apstein CS (2001) Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation 104: 1594-1597
19. Madan S, Dispenzieri A, Lacy MQ, Buadi F, Hayman SR, Zeldenrust SR, Rajkumar SV, Gertz MA, Kumar SK (2010) Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma. Mayo Clin Proc 85: 232-238
20. Merlini G, Seldin DC, Gertz MA (2011) Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 29: 1924-1933
21. Migrino RQ, Hari P, Gutterman DD, Bright M, Truran S, Schlundt B, Phillips SA (2010) Systemic and microvascular oxidative stress induced by light chain amyloidosis. Int J Cardiol 145: 67-68
22. Migrino RQ, Truran S, Gutterman DD, Franco DA, Bright M, Schlundt B, Timmons M, Motta A, Phillips SA, Hari P (2011) Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins. Am J Physiol Heart Circ Physiol 301: H2305-H2312
23. Mishra S, Guan J, Plovie E, Seldin DC, Connors LH, Merlini G, Falk RH, Macrae CA, Liao R (2013) Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol 305: H95-H103
24. Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140: 313-326
25. Ni HM, Bockus A, Wozniak AL, Jones K, Weinman S, Yin XM, Ding WX (2011) Dissecting the dynamic turnover of GFP-LC3 in the autolysosome. Autophagy 7: 188-204
26. Nixon RA (2013) The role of autophagy in neurodegenerative disease. Nat Med 19: 983-997
27. Pastore N, Blomenkamp K, Annunziata F, Piccolo P, Mithbaokar P, Maria Sepe R, Vetrini F, Palmer D, Ng P, Polishchuk E et al (2013) Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency. EMBO Mol Med 5: 397-412
28. Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P et al (2011) TFEB links autophagy to lysosomal biogenesis. Science 332: 1429-1433
29. Shi J, Guan J, Jiang B, Brenner DA, Del Monte F, Ward JE, Connors LH, Sawyer DB, Semigran MJ, Macgillivray TE et al (2010) Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci U S A 107: 4188-4193
30. Shin JT, Ward JE, Collins PA, Dai M, Semigran HL, Semigran MJ, Seldin DC (2012) Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary report. Amyloid 19: 191-196
31. Sikkink LA, Ramirez-Alvarado M (2010) Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture. Cell Death Dis 1: e98
32. Tobin JL, Beales PL (2008) Restoration of renal function in zebrafish models of ciliopathies. Pediatr Nephrol 23: 2095-2099
33. Wong E, Cuervo AM (2010) Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 13: 805-811